Fas antigen expression in liver tissues of patients with chronic hepatitis B

Journal of Hepatology

Volumn 24, Issue 1, 1996, Pages 1-7

  Mochizuki, Kiyoshi ^a   Hayashi, Norio ^a   Hiramatsu, Naoki ^a   Katayama, Kazuhiro ^a   Kawanishi, Yuko ^a   Kasahara, Akinori ^a   Fusamoto, Hideyuki ^a   Kamada, Takenobu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Chronic hepatitis B; Fas antigen

Indexed keywords

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030027743     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80178-4     Document Type: Article

References (31)

1. Dudley FJ, Fox RA, Sherlock S. Cellular immunity and hepatitis-associated Australia antigen liver disease. Lancet 1972; i: 723-6.
2. Edgington TS, Chisari FV Immunological aspects of hepatitis B virus infection. Am J Med Sci 1975; 270: 213-27.
3. McMichael AJ, Ting A, Zweevink HF, Askonas BA. HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature 1977; 270: 524-6.
4. Montano L, Miescher GC, Goodall AH, Wiedmann KH, Janossy G, Thomas HC. Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection. Hepatology 1982; 2: 557-61.
5. Chu CM, Shyu WC, Kuo RW, Liaw YF. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis. Hepatology 1987; 7: 1311-6.
6. Fukusato T, Gerber MA, Thung SN, Ferrone S, Schaffner F. Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol 1986; 123: 264-70.
7. van den Oord JJ, de Vos R, Desmet VJ. In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology 1986; 6: 981-9.
8. Eggink HF, Houthoff HJ, Huitema S, Gips CH, Poppema S. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Clin Exp Immunol 1982; 50: 17-24.
9. Colucci G, Colombo M, Ninno ED, Paronetto F. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis. Gastroenterology 1983; 85: 1138-45.
10. Takehara T, Hayashi N, Katayama K, Kasahara A, Fusamoto H, Kato M, Masuzawa M, Kamada T. Two-dimensional flow cytometric analysis of intrahepatic lymphocyte subsets from patients with chronic hepatitis. Dig Dis Sci 1991; 36: 87-91.
11. Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, Schreiber RD, Schlicht HJ, Huang S, Chisari FV. Class I-restricted cytotoxic T lympocytes are directly cytopathic for their target cells in vivo. J Immunol 1994; 152: 3245-53.
12. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
13. Kerr JFR, Cooksley WGE, Searle J, Halliday JW, Halliday WJ, Holder L, Roberts I, Burnett W, Powell LW. The nature of piecemeal necrosis in chronic active hepatitis. Lancet 1979; ii: 827-8.
14. Searle J, Harmon BV, Bishop CJ, Kerr JFR. The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol 1987; 2: 77-96.
15. Nakamura Y, Ohta G, Kono N, Kobayashi K, Kato Y. Electron microscopic observation of destruction of biliary epithelium in primary biliary cirrhosis. Liver 1983; 3: 238-48.
16. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
17. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747-56.
18. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-43.
19. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 1990; 87: 9620-4.
20. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-9.
21. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-78.
22. 2+-independent T cell-mediated cytotoxity. J Exp Med 1993; 177: 195-200.
23. Kaplan PM, Greanman RL, Gerin JL, Purcell RH, Robinson WS. DNA polymerase associated with human hepatitis B antigen. J Virol 1973; 12: 995-1005.
24. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
25. Russell JH. Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunol Rev 1983; 72: 97-118.
26. Ostergaard HL, Clark WR. Evidence for multiple lytic pathways used by cytotoxic T lymphocyte. J Immunol 1989; 143: 2120-6.
27. Ostergaard HL, Kane KP, Mescher MF, Clark WR. Cytotoxic T lymphocyte mediated lysis without release of serine esterase. Nature 1987; 330: 71-2.
28. Trenn G, Takayama H, Sitkovski MV. Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocyte. Nature 1987; 330: 72-4.
29. Taniguchi A, Clark HB, Johnson EM. Induction of nerve growth factor in Schwann cells after axotomy. Proc Natl Acad Sci USA 1986; 83: 4094-8.
30. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-62.
31. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223-54.